Aviram Mizrachi

rabin medical center

H指数:25

被引数:2,222

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Airway Risk in Angioedema: Validation of a Clinical Triage Algorithm for ENT Referral

血管性水肿的气道风险：用于耳鼻喉科转诊的临床分诊算法验证

OTOLARYNGOLOGY-HEAD AND NECK SURGERY

IF2.5

2026-09-290

OAAI

The Global Immune–Nutrition–Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab

全球免疫-营养-炎症指数（GINI）作为接受西米普利单抗治疗的皮肤鳞状细胞癌患者的候选预后标志物

Cancers

IF4.4

2026-09-050

The prognostic impact of perioperative metabolic variables in head and neck cancer: a prospective study

头颈癌患者围手术期代谢变量的预后影响：一项前瞻性研究

Acta Otorhinolaryngologica Italica

IF2.1

2026-02-010

PRE

The Prognostic Significance of Elective Level 4 Neck Dissection in Oral Tongue Cancer

择区性颈淋巴结清扫术（Level 4）在口腔舌癌中的预后意义

Journal of Surgical Oncology

IF1.9

2026-01-010

OAAI

Prognosis of patients with carotid blowout syndrome in the era of endovascular interventions

颈动脉搏动综合征患者预后的血管内介入治疗时代

ACTA OTORHINOLARYNGOLOGICA ITALICA

IF2.1

2025-12-010

PRE

N-Acetylcysteine Amide Is a Potential Novel Radioprotector of Salivary Gland Function

N-乙酰半胱氨酸酰胺是唾液腺功能的潜在新型放射防护剂

Cancers 2025, Vol. 17, Page 2902

IF4.4

2025-09-040

OAAI

MRSA Necrotizing Fasciitis of the Neck and Chest in a 3-Month-Old Infant

3个月大婴儿的颈部和胸部MRSA坏死性筋膜炎

LARYNGOSCOPE

IF2

2025-09-010

PRE

Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients

程序性死亡-1抑制剂治疗免疫抑制患者非黑色素瘤皮肤癌，并针对实体器官移植患者进行亚组分析

ONCOLOGIST

IF4.2

2025-03-040

The Incidence of Radiologic Evidence of Sinusitis Following Endoscopic Pituitary Surgery: A Multi-Center Study

内镜垂体手术后鼻窦炎放射学证据的发生率: 一项多中心研究

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-08-300

OAAI

A Comparison of Outcomes in Medullary Thyroid Carcinoma Patients With and Without a Preoperative Diagnosis: A Multicenter Retrospective Cohort Study

术前诊断与术前诊断甲状腺髓样癌患者预后的比较: 一项多中心回顾性队列研究

THYROID

IF6.7

2023-05-016

PRE

Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-02-067

OAAI

Editorial: Advances in the Diagnosis and Treatment of Skull Base Tumours

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-251

OAAI

Young non-smokers with oral cancer: What are we missing and why?

ORAL ONCOLOGY

IF3.9

2022-04-0118

OAAI

Adverse Histological Features of Differentiated Thyroid Cancer Are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines

THYROID

IF6.7

2021-12-0314

PRE

Major head and neck surgeries in the elderly population, a match-control study

EJSO

IF2.9

2021-08-015

PREAI

Chemotherapy-induced acute vascular injury involves intracellular generation of ROS via activation of the acid sphingomyelinase pathway

CELLULAR SIGNALLING

IF3.7

2021-06-019

OAAI

Bioelectrical Impedance Analysis in Patients Undergoing Major Head and Neck Surgery: A Prospective Observational Pilot Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-02-025

OAAI

The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study

淋巴结比率对甲状腺髓样癌预后价值的多中心研究

EJSO

IF2.9

2020-11-0124

PREAI

CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma

JOURNAL OF CLINICAL MEDICINE

IF2.9

2020-10-075

OAAI

Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies

检测甲状腺癌肺叶切除术后的复发: 甲状腺球蛋白和甲状腺球蛋白抗体的作用

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2020-03-2752

Aviram Mizrachi

个人简介

教育背景

工作经历

荣誉奖项

研究方向